Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.

How to buy Quidel Corporation stock

Own Quidel Corporation stock in just a few minutes.

Quidel Corporation is a diagnostics & research business based in the US. Quidel Corporation shares (QDEL) are listed on the NASDAQ and all prices are listed in US Dollars. Quidel Corporation employs 1,370 staff and has a trailing 12-month revenue of around 0.00.

How to buy shares in Quidel Corporation

  1. Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – QDEL – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.

Quidel Corporation share price

Use our graph to track the performance of QDEL stocks over time.

Quidel Corporation shares at a glance

Information last updated 2021-04-23.
52-week range$105.93 - $306.72
50-day moving average $132.48
200-day moving average $195.10
Wall St. target price$224.00
PE ratio 6.2374
Dividend yield N/A (0%)
Earnings per share (TTM) $18.60

Buy Quidel Corporation shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
Name Product Stock trade fee Asset types Option trade fee Annual fee Signup bonus
Sofi Invest
$0
Stocks, ETFs, Cryptocurrency
N/A
0%
A free way to invest in stocks, ETFs and crypto.
Robinhood
$0
Stocks, Options, ETFs
$0
0%
Free stock (chosen randomly with a value anywhere between $2.50 and $200)
Sign up using the "go to site" link
Make unlimited commission-free trades in stocks, funds, and options with Robinhood Financial.
Interactive Brokers
$0
Stocks, Bonds, Options, Mutual funds, ETFs, Currencies
$0 + $0.65/contract, $1 minimum
0%
N/A
IBKR Lite offers $0 commissions, and IBKR Pro offers advanced tools for professional traders.
Webull
$0
Stocks, Options, ETFs
$0
0%
Get one free stock valued between $2.50 and $250 when you open an account, one more with a deposit
Open an account
Margin financing rates start at 3.99%. No monthly subscription fees for margin.
Public
$0
Stocks, ETFs
N/A
$0 per month
N/A
loading

Compare up to 4 providers

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy Quidel Corporation stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Is Quidel Corporation under- or over-valued?

Valuing Quidel Corporation stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Quidel Corporation's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

Quidel Corporation's P/E ratio

Quidel Corporation's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 6x. In other words, Quidel Corporation shares trade at around 6x recent earnings.

That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.

Quidel Corporation's PEG ratio

Quidel Corporation's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 7.19. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.

The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Quidel Corporation's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.

Quidel Corporation's EBITDA

Quidel Corporation's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $1.1 billion.

The EBITDA is a measure of a Quidel Corporation's overall financial performance and is widely used to measure a its profitability.

Quidel Corporation financials

Revenue TTM $1.7 billion
Operating margin TTM 64.12%
Gross profit TTM $1.3 billion
Return on assets TTM 47.87%
Return on equity TTM 85.63%
Profit margin 48.76%
Book value $31.51
Market capitalisation $4.8 billion

TTM: trailing 12 months

Shorting Quidel Corporation shares

There are currently 4.1 million Quidel Corporation shares held short by investors – that's known as Quidel Corporation's "short interest". This figure is 12.3% up from 3.6 million last month.

There are a few different ways that this level of interest in shorting Quidel Corporation shares can be evaluated.

Quidel Corporation's "short interest ratio" (SIR)

Quidel Corporation's "short interest ratio" (SIR) is the quantity of Quidel Corporation shares currently shorted divided by the average quantity of Quidel Corporation shares traded daily (recently around 963881.71021378). Quidel Corporation's SIR currently stands at 4.21. In other words for every 100,000 Quidel Corporation shares traded daily on the market, roughly 4210 shares are currently held short.

However Quidel Corporation's short interest can also be evaluated against the total number of Quidel Corporation shares, or, against the total number of tradable Quidel Corporation shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Quidel Corporation's short interest could be expressed as 0.1% of the outstanding shares (for every 100,000 Quidel Corporation shares in existence, roughly 100 shares are currently held short) or 0.156% of the tradable shares (for every 100,000 tradable Quidel Corporation shares, roughly 156 shares are currently held short).

Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Quidel Corporation.

Find out more about how you can short Quidel Corporation stock.

Quidel Corporation share dividends

We're not expecting Quidel Corporation to pay a dividend over the next 12 months.

Quidel Corporation share price volatility

Over the last 12 months, Quidel Corporation's shares have ranged in value from as little as $105.93 up to $306.7236. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Quidel Corporation's is 0.0844. This would suggest that Quidel Corporation's shares are less volatile than average (for this exchange).

Quidel Corporation overview

Quidel Corporation develops, manufactures, and markets diagnostic testing solutions for applications in infectious diseases, cardiology, thyroid, women's and general health, eye health, gastrointestinal diseases, and toxicology worldwide. It offers Sofia and Sofia 2 fluorescent immunoassay systems; QuickVue, a lateral flow immunoassay products; and InflammaDry and AdenoPlus, a POC products to detect infectious and inflammatory diseases and conditions of the eye. The company also provides Triage MeterPro, a portable testing platform that enables physicians to promote enhanced health outcomes, as well as the detection of certain drugs of abuse; Triage BNP test for use on Beckman Coulter lab analyzers; and Triage TOX drug screen, which provides results for the determination of the presence of drug and/or the major metabolites in urine. In addition, it offers traditional cell lines, specimen collection devices, media, and controls for use in laboratories that culture and test for various human viruses, including respiratory and herpes family viruses; and cell-based products comprising tubes, shell vials, and multi-well plates. Further, the company provides biomarkers, which include clinical and research products for the assessment of osteoporosis and the evaluation of bone resorption/formation; and enzyme linked immunosorbent assays and reagents for the detection of activation products. Additionally, it offers Lyra molecular real-time polymerase chain reaction assays; Solana, an amplification and detection system; and Virena, a wireless cellular data management and surveillance system The company markets its products through distributors and direct sales force for use in physician offices, hospitals, clinical laboratories, reference laboratories, universities, retail and urgent care clinics, pharmacies, and wellness screening centers. Quidel Corporation was incorporated in 1979 and is headquartered in San Diego, California.

Frequently asked questions

More guides on Finder

Ask an Expert

You are about to post a question on finder.com:

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • finder.com is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked

Finder.com provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and finder.com Terms of Use.

Questions and responses on finder.com are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site